BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Alamar Biosciences Unveils NULISAseq Inflammation Panel AQ

  January 22, 2025

   · 

  2 min read
• Press Releases

  KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier

  January 22, 2025

   · 

  4 min read
• Press Releases

  Merck KGaA, Darmstadt, Germany Announces Launch of Caregiver Leave Benefit, Strengthening Inclusive Family-Friendly Offerings

  January 22, 2025

   · 

  4 min read
• Press Releases

  Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision

  January 22, 2025

   · 

  10 min read
• 

  Press Releases

  Amebiasis Market Size to Reach USD 37.3 Billion By 2035, Impelled by Urbanization and Poor Sanitation Drive Amebiasis Market Demand

  January 22, 2025

   · 

  8 min read
• 

  Press Releases

  Adenoma Market Expected to Grow at a CAGR of 3.98% during 2025-2035, Impelled by Advancements in Screening and Diagnostic Techniques

  January 22, 2025

   · 

  7 min read
• Press Releases

  Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update

  Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million within five years after commercial launch

  January 22, 2025

   · 

  18 min read
• Press Releases

  U.S. Compounding Pharmacies Market Size to Worth Around USD 9.74 Billion by 2033 | Says Cervicorn Consulting

  January 22, 2025

   · 

  1 min read
• Press Releases

  Segal Trials Leads Phase 2 Schizophrenia Trial of LB-102 Toward Primary Endpoint

  January 22, 2025

   · 

  3 min read
• Press Releases

  Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025

  January 22, 2025

   · 

  12 min read